AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2024
Feb 6, 2024
31228_dirs_2024-02-05_be6f043e-3ac0-4eab-b13d-0a5a94f6437a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2024-02-02
Reporting Person: Peetz Christopher (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-02 | Common Stock | S | 6013 | $26.1918 | Disposed | 104112 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 201570 | Indirect |
Footnotes
F1: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
More from Mirum Pharmaceuticals, Inc.
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
M&A Activity
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18